Clinical Trial Update: Daridorexant to Prevent Post-cardiotomy Delirium [Phase 2]

View source ↗

Summary

A Phase 2 trial sponsored by the University of Rochester is evaluating daridorexant to prevent post-cardiotomy delirium in patients with postoperative cognitive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Cognitive Decline
• Postoperative Delirium

Drugs mentioned

• Daridorexant (daridorexant)

Snippet

Sponsor: University of Rochester | Conditions: Postoperative Cognitive Decline, Postoperative Delirium | Phase 2 | Status: RECRUITING